Skip to main content
Veterinary Medicines

NEOTRIMICINA, 200.000 U.I./ml + 250 mg/ml sospensione iniettabile per bovini, suini, ovini, cani, gatti

Authorised
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate

Product identification

Medicine name:
NEOTRIMICINA, 200.000 U.I./ml + 250 mg/ml sospensione iniettabile per bovini, suini, ovini, cani, gatti
Active substance:
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate
Target species:
  • Cattle
  • Pig
  • Sheep
  • Dog
  • Cat
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Benzylpenicillin procaine
    200000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Dihydrostreptomycin sulfate
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        74
        day
      • Milk
        8
        day
    • Pig
      • Meat and offal
        74
        day
    • Sheep
      • Meat and offal
        74
        day
      • Milk
        8
        day
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA01
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Salute Animale S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetem S.p.A.
  • Ceva Sante Animale
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 24/07/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."